Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06519162
What this trial is testing

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

Who this might be right for
Autoimmune HepatitisPrimary Sclerosing CholangitisNon-Alcoholic Fatty Liver Disease+2 more
Chungnam National University Hospital 3,000
Not applicableUnknownNCT03749070
What this trial is testing

Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease - The SILIVER Trial

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Camila Ribeiro de Avelar 132
Not applicableLooking for participantsNCT07270601
What this trial is testing

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease
ContextVision AB 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07320456
What this trial is testing

A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver Disease

Who this might be right for
Hepatic Steatosis
Shanghai Municipal Hospital of Traditional Chinese Medicine 80
Testing effectiveness (Phase 2)Study completedNCT02217345
What this trial is testing

Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Massachusetts General Hospital 131
Not applicableUnknownNCT06450769
What this trial is testing

Aronia and Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Istanbul Kent University 54
Not applicableStudy completedNCT04524936
What this trial is testing

Serum Irisin Levels in Obese Children

Who this might be right for
Serum Irisin Levels in Obese Children
Eskisehir Osmangazi University 90
Not applicableUnknownNCT02122263
What this trial is testing

Transient Elastography of the Liver ( Fibroscan ) and Bariatric Surgery

Who this might be right for
NAFLD
Ziv Hospital 60
Not applicableStudy completedNCT00977730
What this trial is testing

The Effect of Protandim on Non-alcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Steatohepatitis
University of Colorado, Denver 70
Large-scale testing (Phase 3)Study completedNCT02395900
What this trial is testing

The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 50
Not applicableStudy completedNCT06344364
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,241
Not applicableStudy completedNCT01985009
What this trial is testing

Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.

Who this might be right for
Non-alcoholic Fatty Liver Disease
Echosens 450
Not applicableStudy completedNCT04452409
What this trial is testing

Enhanced Liver Function in Non-alcoholic Obese Fatty Liver Patients by Low Level Laser Therapy

Who this might be right for
Fatty Liver, NonalcoholicLiver Function
Cairo University 60
Not applicableStudy completedNCT01696487
What this trial is testing

Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNon-alcoholic Steatohepatitis
Medical University of Vienna 10
Not applicableStudy completedNCT04616664
What this trial is testing

Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"

Who this might be right for
ObesityNASH - Nonalcoholic Steatohepatitis
University Hospital, Lille 158
Testing effectiveness (Phase 2)Looking for participantsNCT06588699
What this trial is testing

Digoxin In NASH (CODIN)

Who this might be right for
NASHNAFLDMASH - Metabolic Dysfunction-Associated Steatohepatitis+5 more
Yale University 144
Large-scale testing (Phase 3)Study completedNCT01754714
What this trial is testing

Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group

Who this might be right for
Non Alcoholic Fatty Liver Disease
Abbott 108
Testing effectiveness (Phase 2)Study completedNCT00063232
What this trial is testing

Treating Nonalcoholic Steatohepatitis (NASH) With Metformin

Who this might be right for
Hepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 28
Not applicableStudy completedNCT04435054
What this trial is testing

Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Hospices Civils de Lyon 1,000
Not applicableStudy completedNCT07825467
What this trial is testing

Brown Adipose Tissue Activity and NAFLD Progression

Who this might be right for
Nonalcoholic Fatty Liver Disease
Renmin Hospital of Wuhan University 96
Next Page